Stocks · Health care · Pharmaceutical Preparations

Mirum Pharmaceuticals, Inc.

MIRM Clue Score61
United States Fiscal year ends December CIK 0001759425 Results filed 3 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Christopher Peetz
4 Nov 2026
Chief Executive Officer
Sold after exercise
20,000
$90.00
$1.80M
Jolanda Howe
16 Oct 2026
SVP, Global Controller
Exercised, kept
16,112
$19.24
$309.99K
Christopher Peetz
6 Oct 2026
Chief Executive Officer
Exercised, kept
6,892
$15.87
$109.38K
Christopher Peetz
6 Oct 2026
Chief Executive Officer
Exercised, kept
5,305
$19.19
$101.80K

What was left out

Form 4 filings counted 4
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 48,309
History held since 18 Jul 2019